Why the Neutral Stance?
Hancock�� focus on its organic growth strategy as well as expansion through acquisitions prompted us to initiate with this stance. Further, the company continues to build capital, resulting in a better financial position that will help in fulfilling the stringent capital requirements. Moreover, with a strong liquidity position and meaningful capital deployment, Hancock remains an asset for yield-seeking investors.
Nevertheless, due to the low interest rate environment, Hancock is expected to continue experiencing pressure on its net interest margin. Moreover, increased non-interest expenses and significant exposure to real estate markets remain major causes of concern for the company. In addition, Hancock�� profitability remains subject to the stringent regulatory landscape.
Top Regional Bank Companies To Watch In Right Now: Altisource Portfolio Solutions S.A.(ASPS)
Altisource Portfolio Solutions S.A., together with its subsidiaries, provides services related to real estate and mortgage portfolio management, asset recovery, and customer relationship management primarily in the United States. Its Mortgage Services segment offers mortgage portfolio management services to loan originators and loan servicers. This segment provides asset management services that primarily include property preservation, property inspection, real estate owned (REO) asset management, and REO brokerage; residential property valuation; closing and title services; default management services, such as non-legal back-office support for foreclosure, bankruptcy, and eviction attorneys, as well as foreclosure trustee services. The company?s Financial Services segment offers unsecured asset recovery management services, including post-charge-off consumer debt collection that comprise credit cards, auto loans, and second mortgages; and customer relationship management services, such as customer care and early stage collection. Its Technology Services segment provides integrated technological solutions for loan servicing, vendor management, and invoice presentment and payment; and IT infrastructure services, such as desktop management, application support, network management, telephony, data center management, disaster recovery, helpdesk, and infrastructure security. This segment offers REALSuite of applications consisting of REALServicing, an enterprise residential mortgage loan servicing platform; REALTrans, an electronic business-to-business exchange that automates and simplifies the ordering, tracking, and fulfilling of mortgage and other services; and REALRemit, an electronic invoicing and payment system. The company serves sub-prime servicers, utility companies, commercial banks, servicers, mortgage bankers, and financial service companies, as well as hedge funds. Altisource Portfolio Solutions S.A. was incorporated in 1999 and is b ased in Luxembourg.
Advisors' Opinion:- [By Amanda Alix]
While these companies are still heavily involved, there is also a new presence on the scene: the single-family home REIT. Last December, mortgage REIT Two Harbors (NYSE: TWO ) spun off Silver Bay Realty (NYSE: SBY ) after selling its stable of 3,100 homes to Silver Bay prior to its initial public offering. Around the same time, Altisource Residential�was also born, spun off from Altisource Portfolio Solutions (NASDAQ: ASPS ) .
- [By Amanda Alix]
For Wall Street types, single-family foreclosures can be bought cheaply and in bulk, then fixed up and rented. Companies like the Blackstone Group (NYSE: BX ) and Colony Financial (NYSE: CLNY ) have been very active in this market, with the former purchasing 16,000 homes just last year, and the latter ramping up its own portfolio to approximately 7,000. This new industry has also spawned fresh entrants from the REIT field, Silver Bay Realty (NYSE: SBY ) and Altisource Residential, (NYSE: RESI ) two trusts that were spun off earlier this year from parent companies Two Harbors Investment (NYSE: TWO ) and Altisource Portfolio Solutions (NASDAQ: ASPS ) , specifically to take advantage of the boom in the foreclosure-to-rental market.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Altisource Portfolio Solutions (Nasdaq: ASPS ) , whose recent revenue and earnings are plotted below.
Top Regional Bank Companies To Watch In Right Now: Kansas City Southern (KSU)
Kansas City Southern, through its subsidiaries, engages primarily in the freight rail transportation business. It operates north/south rail between Kansas City, Missouri, and various ports along the Gulf of Mexico in Alabama, Louisiana, Mississippi, and Texas in the midwest and southeast regions of the United States. The company also operates direct rail passageway between Mexico City and Laredo in Texas, serving various Mexico?s industrial cities and 3 of its shipping ports; and a 157-mile rail line extending from Laredo, Texas to the port city of Corpus Christi, Texas, as well as owns the northern half of the rail bridge at Laredo, Texas. In addition, Kansas City Southern holds a concession to operate a 47-mile railroad located adjacent to the Panama Canal, as well as operates and promotes commuter and tourist passenger services. Further, the company operates a bulk materials handling facility with deep-water access to the Gulf of Mexico at Port Arthur, Texas that stores and transfers petroleum coke from rail cars to ships primarily for export; and a railroad wood tie treatment facility. It serves customers conducting business in various industries, including electric-generating utilities, chemical and petroleum products, industrial and consumer products, agriculture and mineral products, automotive products, and intermodal freight transportation. The company was formerly known as Kansas City Southern Industries, Inc. and changed its name to Kansas City Southern in 2002. Kansas City Southern was founded in 1962 and is based in Kansas City, Missouri.
Advisors' Opinion:- [By Ben Levisohn]
If January’s selloff was all about the emerging markets, February’s is all about the U.S, as fears of a weaker economy have helped drag down 3M (MMM), United Technologies (UTX), General Electric (GE), Whirlpool (WHR) and Kansas City Southern (KSU).
Hot Information Technology Stocks To Own For 2015: PRGX Global Inc.(PRGX)
PRGX Global, Inc., together with its subsidiaries, provides recovery audit, healthcare claims recovery audit, and analytics and advisory services. The company?s recovery audit services are based on the mining and auditing of clients? purchasing data for overpayments to suppliers; and healthcare claims recovery audit services consist of identification of overpayments and underpayments made to healthcare providers, such as hospitals and physicians? practices. Its analytics and advisory services focuses on client functional and process areas and provides services to senior finance executives to optimize working capital, reduce enterprise costs, transform the finance function, and enhance corporate performance. The company serves retailers, such as discount, department, specialty, grocery, and drug stores; business enterprises, including manufacturers, financial services firms, and pharmaceutical companies; private sector health insurance companies, and state and federal go vernment payers consisting of the centers for Medicare and Medicaid Services; and federal and state government agencies. It has operations in the United States, Canada, rest of Latin America, Europe, Asia, and rest of the Pacific region. The company was formerly known as PRG-Schultz International, Inc. and changed its name to PRGX Global, Inc. in January 2010. PRGX Global, Inc. was founded in 1990 and is based in Atlanta, Georgia.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on PRGX Global (Nasdaq: PRGX ) , whose recent revenue and earnings are plotted below.
Top Regional Bank Companies To Watch In Right Now: Airbus Group NV (EADSF)
Airbus Group NV, known as European Aeronautic Defence and Space Company EADS NV, is a Netherlands-based company active within the aerospace and defense sector. The Company manufactures aircrafts, helicopters, commercial space launch vehicles, missiles, satellites, defense systems and defense electronics, and offers services related to these activities. The Company oprates four divisions. The Airbus division comprises the Airbus Commercial and Airbus Military segments, which develop, manufacture, market and sell commercial jet aircrafts, military transport aircrafts and special mission aircrafts, among others. The Eurocopter division develops, markets and sells civil and military helicopters. The Astrium division develops, manufactures and sells satellites, orbital infrastructures and launchers, as well as provides space-related services. The Cassidian division develops, manufactures and sells missiles systems, military combat and training aircrafts, among others. Advisors' Opinion:- [By CNNMoney Staff]
Shares in Airbus (EADSF) were rising by 5% in Europe after the firm reported better-than-expected quarterly results.
Investors will also be focusing on developments in the pharmaceutical industry Tuesday. The American drug maker Pfizer (PFE, Fortune 500) wants to buy Britain's AstraZeneca (AZN) and both CEOs will appear before a U.K. parliamentary committee to answer questions about the potential takeover.
- [By Rich Smith]
European plane maker and EADS (NASDAQOTH: EADSF ) subsidiary Airbus announced Monday that one of its biggest, and most expensive planes, has just secured a big place in the airplane lineup at British Airways (BA).
- [By Alanna Petroff]
Airbus, part of the pan-European aerospace conglomerate EADS (EADSF), is hoping that all airlines will adopt the 18-inch standard for long-haul flights.
- [By Alanna Petroff]
4. Earnings and economics: Shares in Airbus Group (EADSF) are rising by about 3% in Europe after the firm reported better than expected quarterly earnings.
Top Regional Bank Companies To Watch In Right Now: Chelsea Therapeutics International Ltd.(CHTP)
Chelsea Therapeutics International, Ltd., a development-stage pharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutic products for the treatment of various human diseases. It is involved in developing Droxidopa, a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) associated with primary autonomic failure and falls related to NOH in Parkinson?s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension, fibromyalgia, adult attention deficit hyperactivity disorder, chronic fatigue syndrome, and freezing of gait in PD and down syndrome. The company intends to market its Droxidopa drug under the Northera brand name. It also engages in developing a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, including rheumatoid arthritis, psoriasis, Crohn?s disease, ankylosing spondylitis, uveitis, psoriatic arthritis, inflammatory bowel disease, cancer, and other immunological disorders. The company?s molecule products include a portfolio of metabolically inert antifolate molecules consisting of CH-1504 and CH-4051, which are orally available molecules with anti-inflammatory, autoimmune, and anti-tumor properties that inhibit various key enzymes required for cell proliferation; and a portfolio of dihydroorotate dehydrogenase, known as the I-3D portfolio, for applications in autoimmune diseases and transplantation. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.
Advisors' Opinion:- [By Lauren Pollock]
Chelsea Therapeutics International Ltd.(CHTP) said an offering of 6.67 million shares priced at $3 each, a 9.9% discount to Tuesday’s close. The development-stage pharmaceutical company said it intends to use the proceeds to fund its droxidopa program, including regulatory and possible initial commercialization activity for its lead investigational drug candidate Northera, and for general corporate purposes. Shares dropped.
- [By Jon C. Ogg]
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is finding a serious victory from its hypotension drug. Shares hit a 52-week high — make that a three-year high — after the company confirmed an accelerated FDA approval of its Northera for the treatment of low blood pressure, following FDA panel backing just last month.
Top Regional Bank Companies To Watch In Right Now: EMCORE Corporation(EMKR)
EMCORE Corporation, together with its subsidiaries, provides compound semiconductor-based products for the broadband, fiber optics, satellite, and solar power markets. The company operates in two segments, Fiber Optics and Photovoltaics. The Fiber Optics segment offers broadband products, including cable television, fiber-to-the-premises, satellite communication, video transport, and defense and homeland security products; and digital products comprising telecom optical, enterprise, laser/photodetector component, parallel optical transceiver and cable, and fiber channel transceiver products. This segment?s products enable information that is encoded on light signals to be transmitted, routed, and received in communication systems and networks. The Photovoltaics segment provides gallium arsenide (GaAs) multi-junction solar cells, covered interconnected cells, and solar panels for satellite applications; and concentrating photovoltaic (CPV) power systems for commercial and utility scale solar applications, as well as GaAs solar cells and integrated CPV components for use in other solar power concentrator systems. The company markets its products through its direct sales force, external sales representatives and distributors, and application engineers worldwide. EMCORE Corporation was founded in 1984 and is headquartered in Albuquerque, New Mexico.
Advisors' Opinion:- [By Roberto Pedone]
EMCORE (EMKR), together with its subsidiaries, provides compound semiconductor-based products for the broadband, fiber optics, satellite, and solar power markets. This stock closed up 1% to $4.09 in Tuesday's trading session.
Tuesday's Range: $4.00-$4.14
52-Week Range: $3.50-$5.62
Tuesday's Volume: 187,000
Three-Month Average Volume: 103,744From a technical perspective, EMKR trended modestly higher here back above its 50-day moving average of $4.03 with above-average volume. This stock has been making higher lows over the last three months each time it has pulled back, which is a bullish technical sign. This spike to the upside on Tuesday is starting to push shares of EMKR within range of triggering a big breakout trade. That trade will hit if EMRK manages to take out some key near-term overhead resistance levels at $4.16 to $4.20 and then above $4.22 with high volume.
Traders should now look for long-biased trades in EMKR as long as it's trending above some key near-term support levels at $3.90 to $3.86 or above more support at $3.78 and then once it sustains a move or close above those breakout levels with volume that hits near or above 103,744 shares. If that breakout gets underway soon, then EMKR will set up to re-test or possibly take out its next major overhead resistance levels at $4.53 to its 200-day moving average of $4.65, or even $5 to $5.30.
Top Regional Bank Companies To Watch In Right Now: Hyperion Therapeutics Inc (HPTX)
Hyperion Therapeutics, Inc. (Hyperion), incorporated in November 2006, is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. The Company develops Ravicti (glycerol phenylbutyrate) to treat the prevalent urea cycle disorders (UCD) and hepatic encephalopathy (HE). The Company has completed two Phase II trials and one pivotal Phase III trial of Ravicti. The Company�� HE clinical program consists of two trials, which have enrolled patients with cirrhosis. On December 23, 2011, the Company submitted a new drug application (NDA) for Ravicti for the chronic management of UCD in patients aged six years and above based on data from its pivotal Phase III trial in adult patients and the results of two Phase II trials, one in adults and one in pediatric patients aged 6 through 17 years. In June 2013, Hyperion Therapeutics Inc announced that the completion of its acquisition of BUPHENYL (sodium phenylbutyrate) Tablets and Powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharmaceuticals International, Inc.
In June 2011, the Company completed a 24-month carcinogenicity study of Ravicti in rats. On March 22, 2012, pursuant to an asset purchase agreement (purchase agreement) with Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation, the Company purchased all of the worldwide rights to Ravicti. The Company also has an option to acquire all of Ucyclyd�� worldwide rights in BUPHENYL and AMMONUL (sodium phenylacetate and sodium benzoate) injection.
The Company conducted a pivotal Phase III trial of Ravicti in adult patients 18 years of age or older with UCD. The Company completed a second Phase II trial at five centers in North America in UCD patients aged 6 through 17 years. This trial includes two phases: a two-week, open-label, safety, tolerability, pharmacokinetic characteristics and ammonia control of Ravicti. The Co! mpany enrolled 77 adult and pediatric UCD patients in its two 12-month open-label safety studies, 69 of whom completed the studies. The Company conducted nonclinical genotoxicity and carcinogenicity studies to assess the tumorigenic potential of Ravicti in animals and to assess the relevant risk in humans. The Company is conducting a Phase II multi-center study of patients with cirrhosis and episodic HE.
Advisors' Opinion:- [By Jesse Solomon]
NPS Pharmaceuticals (NPSP), for example, created a drug for treating short bowel syndrome. And Hyperion Therapeutics (HPTX) is developing a drug for hepatic encephalopathy, a decline of brain function that according to the National Institute of Health occurs when the liver is no longer able to remove toxins from the blood. Those stocks are up 20% and 40%, respectively, this year.
- [By Sean Williams]
What: Shares of Hyperion Therapeutics (NASDAQ: HPTX ) , a biopharmaceutical company focused on treatments for orphan diseases and hepatology, rose as much as 10% after receiving orphan drug exclusivity status for Ravicti from the Food and Drug Administration, and exercising an option to acquire two additional urea cycle drugs from Valeant Pharmaceuticals (NYSE: VRX ) .
Top Regional Bank Companies To Watch In Right Now: Schawk Inc.(SGK)
Schawk, Inc., together with its subsidiaries, provides graphic services and solutions in the Americas, Europe, and the Asia Pacific. The company?s graphic services encompasses a range of creative and executional service offerings, including traditional premedia business services, as well as digital photography, color retouching, large format digital printing, and sales and promotional samples under the Schawk brand name; and digital three-dimensional modeling of prototypes or existing packages for its consumer products clients. Its brand and package strategy and design services include brand consulting and creative design for packaging applications to consumer products companies, food and beverage retailers, and mass merchandisers under the Brandimage and Anthem brands. The company also offers digital promotion and advertising services to the digital communications markets under the Untitled and Real Branding brand names. In addition, it provides software products, such a s graphic lifecycle content management systems comprising digital asset management, workflow management, online proofing, and intelligence performance management modules; and support services, which include implementation, on-site management, validation for regulated environments, and support and training for the marketing services departments of consumer products, pharmaceutical/life sciences, and retail companies. The company serves direct purchasers of graphic services, including end-use consumer product manufacturers of food, beverage, non-food and beverage, and pharmaceutical products; groceries, pharmacies, department, and mass merchant retailers; converters; and advertising agencies. Schawk, Inc. was founded in 1953 and is headquartered in Des Plaines, Illinois.
Advisors' Opinion:- [By Seth Jayson]
There's no foolproof way to know the future for Schawk (NYSE: SGK ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
No comments:
Post a Comment